Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
As of 5 November 2013, Ambu’s single-use videoscope – aScope 3 – has received market clearance from the U.S. Food and Drug Administration (FDA) for sale in the US, which means that Ambu will launch...
-
King Systems – owned by Ambu A/S – has received a Warning Letter from the U. S. Food and Drug Administration (FDA) relating to an inspection of the King Systems manufacturing site in Noblesville,...
-
King Systems – som er ejet af Ambu A/S – har modtaget et Warning Letter fra FDA (the U. S. Food and Drug Administration) i forbindelse med en inspektion af King Systems-fabrikken i Noblesville, USA....
-
Finanskalender for 2013/14 er vedlagt...
-
Financial Diary 2013/14 is attached!...
-
I henhold til selskabslovens §55 og Værdipapirhandelslovens §29 skal vi herved meddele, at ATP efter salg har reduceret sine ejer- og stemmeandele i Ambu A/S. ATP ejer herefter under 5% af...
-
According to § 55 of the Danish Company Act (Selskabsloven) and § 29 of the Danish Securities Trading Act (Værdipapirhandelsloven) , we hereby report that ATP after sale of shares has reduced their...
-
Vi skal hermed i henhold til Værdipapirhandelslovens § 29 og Selskabslovens § 55 meddele, at Inga Kovstrup, Brandsøvej 17, Skærbæk, 7000 Fredericia har reduceret sin beholdning af aktier i Ambu A/S....
-
According to § 29 of the Danish Securities Trading Act (Værdipapirhandelsloven) and § 55 of the Danish Company Act (Selskabsloven), we hereby report that Inga Kovstrup, Brandsøvej 17, Skærbæk, 7000...
-
In pursuance of Section 28 a, Subsection 5 of the Danish Securities Trading Act (Værdipapirhandelsloven), Ambu A/S hereby reports the following information, which the company has received on 4...